Smoking and interstitial lung diseases

European Respiratory Review

Volumn 24, Issue 137, 2015, Pages 428-435

  Margaritopoulos, George A ^a   Vasarmidi, Eirini ^b   Jacob, Joseph ^a   Wells, Athol U ^a   Antoniou, Katerina M ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYTOKINE; DNA METHYLTRANSFERASE 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTONE H4; NICOTINE; NICOTINIC RECEPTOR; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; GENETIC MARKER;

AGING; APOPTOSIS; AUTOPHAGY; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DNA DAMAGE; EPIGENETICS; HUMAN; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LANGERHANS CELL HISTIOCYTOSIS; LUNG ALVEOLUS MACROPHAGE; MITOPHAGY; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SMOKING; ADVERSE EFFECTS; COMPUTER ASSISTED TOMOGRAPHY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; LUNG DISEASES, INTERSTITIAL; METABOLISM; PHENOTYPE; PREVENTION AND CONTROL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG DISEASES, INTERSTITIAL; PHENOTYPE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84940647163     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0050-2015     Document Type: Review

References (94)

1. Houghton M, Mouded M, Shapiro SD. Common origins of lung cancer and COPD. Nat Med 2008; 14: 1023–1024.
2. American Thoracic Society. Cigarette smoking and health. Am J Respir Crit Care Med 1996; 153: 861–865.
3. Murin S, Hilbert J, Reilly SJ. Cigarette smoking and the lung. Clin Rev Allergy Immunol 1997; 15: 307–361.
4. Vassallo R, Ryu JH. Smoking-related interstitial lung diseases. Clin Chest Med 2012; 33: 165–178.
5. Caminati A, Cavazza A, Sverzellati N, et al. An integrated approach in the diagnosis of smoking-related interstitial lung diseases. Eur Respir Rev 2012; 21: 207–217.
6. Wells AU, Nicholson AG, Hansell DM. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax 2007; 62: 904–910.
7. Peros-Golubicic T, Ljubic S. Cigarette smoking and sarcoidosis. Acta Med Croatica 1995; 49: 187–193.
8. Sieminska A, Kuziemski K. Respiratory bronchiolitis-interstitial lung disease. Orphanet J Rare Dis 2014; 9: 106.
9. D’hulst AI, Vermaelen KY, Brusselle GG, et al. Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J 2005; 26: 204–213.
10. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smokers. N Engl J Med 1974; 291: 755–758.
11. Remy-Jardin M, Remy J, Gosselin B, et al. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993; 186: 643–651.
12. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol 2002; 26: 647–653.
13. Moon J, du Bois RM, Colby TV, et al. Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999; 54: 1009–1014.
14. Rahman S, Biswas K, Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006; 533: 222–239.
15. Van der Vaart H, Postma DS, Timens W, et al. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 2004; 59: 713–721.
16. Zavitz CC, Gaschler GJ, Robbins CS, et al. Impact of cigarette smoke on T and B cell responsiveness. Cell Immunol 2008; 253: 38–44.
17. Rennard SI, Togo S, Holz O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proc Am Thorac Soc 2006; 3: 703–708.
18. Kuschner WG, D’Alessandro A, Wong H, et al. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9: 1989–1994.
19. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258–J265.
20. Lu LM, Zavitz CC, Chen B, et al. Cigarette smoke impairs NK cell-dependent tumor immune surveillance. J Immunol 2007; 178: 936–943.
21. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res 2006; 7: 132.
22. Vassallo R, Tamada K, Lau JS, et al. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005; 175: 2684–2691.
23. Israel-Assayag E, Dakhama A, Lavigne S, et al. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999; 159: 1830–1834.
24. Hodge S, Hodge G, Ahern J, et al. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007; 37: 748–755.
25. Tomita K, Caramori G, Lim S, et al. Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-xL expression and reduced apoptosis in alveolar macrophages from smokers. Am J Respir Crit Care Med 2002; 166: 724–731.
26. Prasse A, Stahl M, Schulz G, et al. Essential role of osteopontin in smoking-related interstitial lung diseases. Am J Pathol 2009; 174: 1683–1691.
27. Jensen K, Nizamutdinov D, Guerrier M, et al. General mechanisms of nicotine-induced fibrogenesis. FASEB J 2012; 26: 4778–4787.
28. Roomans GM, Vanthanouvong V, Dragomir A, et al. Effects of nicotine on intestinal and respiratory epithelium. J Submicrosc Cytol Pathol 2002; 34: 381–388.
29. Arany I, Reed DK, Grifoni SC, et al. A novel U-STAT3-dependent mechanism mediates the deleterious effects of chronic nicotine exposure on renal injury. Am J Physiol Renal Physiol 2012; 302: F722–F729.
30. Soeda J, Morgan M, McKee C, et al. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem Biophys Res Commun 2012; 417: 17–22.
31. Wang RD, Wright JL, Churg A. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005; 33: 387–393.
32. Talikka M, Sierro N, Ivanov NV, et al. Genomic impact of cigarette smoke, with application to three smoking-related diseases. Crit Rev Toxicol 2012; 42: 877–889.
33. Yang SR, Chida AS, Bauter MR, et al. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 2006; 291: L46–L57.
34. Yang IV. Epigenomics of idiopathic pulmonary fibrosis. Epigenomics 2012; 4: 195–203.
35. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005; 25: 552–563.
36. Coward WR, Watts K, Feghali-Bostwick CA, et al. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 2009; 29: 4325–4339.
37. Coward WR, Watts K, Feghali-Bostwick CA, et al. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol Cell Biol 2010; 30: 2874–2886.
38. Lake F, Proudman S. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med 2014; 35: 222–238.
39. Samara KD, Margaritopoulos G, Wells AU, et al. Smoking and pulmonary fibrosis: novel insights. Pulm Med 2011; 2011: 461439.
40. Fischer A, Solomon JJ, du Bois RM, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012; 106: 1040–1047.
41. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54: 38–46.
42. Harlow L, Rosas IO, Gochuico BR, et al. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum 2013; 65: 869–879.
43. Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis 2014; 73: 1487–1494.
44. Antoniou KM, Margaritopoulos GA, Tomassetti S, et al. Interstitial lung disease. Eur Respir Rev 2014; 23: 40–54.
45. Faner R, Rojas M, Macnee W, et al. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012; 186: 306–313.
46. Morse D, Rosas IO. Tobacco smoke-induced lung fibrosis and emphysema. Annu Rev Physiol 2014; 76: 493–513.
47. Collard HR. The age of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 181: 771–772.
48. Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res 2012; 13: 3.
49. López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell 2013; 153: 1194–1217.
50. Borie R, Crestani B, Bichat H. Prevalence of telomere shortening in familial and sporadic pulmonary fibrosis is increased in men. Am J Respir Crit Care Med 2009; 179: 1073.
51. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat Res 2012; 730: 52–58.
52. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356: 1317–1326.
53. Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 2004; 359: 109–121.
54. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005; 366: 662–664.
55. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004; 567: 447–474.
56. Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 2007; 317: 807–810.
57. Jones DP. Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res 2006; 9: 169–181.
58. Ryter SW, Lee SJ, Choi AMK. Autophagy in cigarette smoke–induced chronic obstructive pulmonary disease. Expert Rev Respir Med 2010; 4: 573–584.
59. Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet 2008; 24: 604–612.
60. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 651–662.
61. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013; 13: 722–737.
62. Nakahira K, Choi AM. Autophagy: a potential therapeutic target in lung diseases. Am J Physiol Lung Cell Mol Physiol 2013; 305: L93–L107.
63. Margaritopoulos GA, Tsitoura E, Tzanakis N, et al. Self-eating: friend or foe? The emerging role of autophagy in idiopathic pulmonary fibrosis. Biomed Res Int 2013; 2013: 420497.
64. Wang CH, Wu SB, Wu YT, et al. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) 2013; 238: 450–460.
65. Palikaras K, Tavernarakis N. Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol 2014; 56: 182–188.
66. Sureshbabu A, Bhandari V. Targeting mitochondrial dysfunction in lung diseases: emphasis on mitophagy. Front Physiol 2013; 4: 384.
67. Chen ZH, Kim HP, Sciurba FC, et al. Egr-1 regulates autophagy in cigarette smoke–induced chronic obstructive pulmonary disease. PLoS One 2008; 3: e3316.
68. Chen ZH, Lam HC, Jin Y, et al. Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke–induced emphysema. Proc Natl Acad Sci USA 2010; 107: 18880–18885.
69. Monick MM, Powers LS, Walters K, et al. Identification of an autophagy defect in smokers’ alveolar macrophages. J Immunol 2010; 185: 5425–5435.
70. Ballweg K, Mutze K, Königshoff M, et al. Cigarette smoke extract affects mitochondrial function in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2014; 307: L895–L907.
71. Hoffmann RF, Zarrintan S, Brandenburg SM, et al. Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells. Respir Res 2013; 14: 97.
72. Hara H, Araya J, Ito S, et al. Mitochondrial fragmentation in cigarette smoke-induced bronchial epithelial cell senescence. Am J Physiol Lung Cell Mol Physiol 2013; 305: L737–L746.
73. Ahmad T, Sundar IK, Lerner CA, et al. Impaired mitophagy leads to cigarette smoke stress-induced cellular senescence: implications for chronic obstructive pulmonary disease. FASEB J 2015; 29: 2912–2929.
74. Patel AS, Lin L, Geyer A, et al. Autophagy in idiopathic pulmonary fibrosis. PLoS One 2012; 7: e41394.
75. Patel AS, Song JW, Chu SG, et al. Epithelial cell mitochondrial dysfunction and PINK1 are induced by transforming growth factor-beta1 in pulmonary fibrosis. PLoS One 2015; 10: e0121246.
76. Bueno M, Lai YC, Romero Y, et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest 2015; 125: 521–538.
77. Margaritopoulos GA, Giannarakis I, Siafakas NM, et al. An update on idiopathic pulmonary fibrosis. Panminerva Med 2013; 55: 109–120.
78. Hubbard R, Lewis S, Richards K, et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347: 284–289.
79. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242–248.
80. Rosas IO, Ren P, Avila NA, et al. Early interstitial lung disease in familial pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176: 698–705.
81. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011; 364: 897–906.
82. Jin GY, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013; 268: 563–571.
83. Sverzellati N, Guerci L, Giorgia R, et al. Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2011; 38: 392–400.
84. Flaherty KR, Fell C, Aubry MC, et al. Smoking-related idiopathic interstitial pneumonia. Eur Respir J 2014; 44: 594–602.
85. King TE, Schwarz MI, Brown K, et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025–1032.
86. Wells AU, Desai SR, Rubens MB, et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: 962–969.
87. Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 177: 190–194.
88. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586–593.
89. Zappala CJ, Latsi PI, Nicholson AG, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010; 35: 830–836.
90. Cottin V, Le Pavec J, Prevot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J 2010; 35: 105–111.
91. Antoniou KM, Walsh SL, Hansell DM, et al. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung. Respirology 2013; 18: 1191–1196.
92. Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63: 295–304.
93. Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010; 35: 496–504.
94. Tomassetti S, Gurioli C, Ryu JH, et al. The impact of lung cancer on survival of idiopathic pulmonary fibrosis. Chest 2015; 147: 157–164.